Monkeypox
Symptoms, Doctors, Treatments, Advances & More

Monkeypox Overview

Save information for later
Sign Up

Learn About Monkeypox

What is the definition of Monkeypox?
Monkeypox is a rare viral infection caused by the monkeypox virus. The monkeypox virus is in the same family of viruses that cause smallpox. However, an infection with monkeypox is usually milder than smallpox.
What are the causes of Monkeypox?
Monkeypox can be contracted through skin-to-skin contact with an infected person or their body fluids, breathing in the virus through face-to-face contact, through sexual contact, touching items that were used by an infected person, from maternal-to-infant transmission during pregnancy, and bites from infected animals.
What are the symptoms of Monkeypox?
Symptoms of monkeypox usually appear three weeks after exposure to the virus. Symptoms of monkeypox vary by individual and can be mild to severe. Symptoms of monkeypox may include a rash that looks like pimples or blisters, headache, fatigue, fever, sore throat, nasal congestion, cough, chills, muscle aches, backache, and swollen lymph nodes. The rash may appear on the genitals, anus, mouth, face, chest, and hands. The pimples or blisters may be painful and itchy. The rash progresses to scabs before healing. Individuals with monkeypox remain contagious to others until all the scabs have completely healed, usually within two-to-four weeks.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Monkeypox?
Mild monkeypox infections will usually heal without treatment within two-to-four weeks. Treatment for monkeypox includes antiviral drugs such as tecovirimat, prescription mouthwashes, stool softeners, and topical gels and creams.
Who are the top Monkeypox Local Doctors?
Elite in Monkeypox
Dr. Inger Damon
Internal Medicine
Elite in Monkeypox
Dr. Inger Damon
Internal Medicine

Office

1627 Clairmont Ln NE, 
Atlanta, GA 
404-717-5167
Languages Spoken:
English

Inger Damon is an Internal Medicine provider practicing medicine in Atlanta, Georgia. Dr. Damon is rated as an Elite provider by MediFind in the treatment of Monkeypox. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Monkeypox, Smallpox, Rabies, and Ebola Virus Disease.

Elite in Monkeypox
Elisabeth S. Pukuta
Elite in Monkeypox
Elisabeth S. Pukuta
Referral may be required
Kinshasa, KN, CD 

Elisabeth Pukuta practices practicing medicine in Kinshasa, Democratic Republic of the Congo. Ms. Pukuta is rated as an Elite expert by MediFind in the treatment of Monkeypox. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Monkeypox, Rabies, Ebola Virus Disease, and Viral Hemorrhagic Fever.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Monkeypox
Stomy S. Karhemere
Elite in Monkeypox
Stomy S. Karhemere
Referral may be required
Kinshasa, KN, CD 

Stomy Karhemere practices practicing medicine in Kinshasa, Democratic Republic of the Congo. Karhemere is rated as an Elite expert by MediFind in the treatment of Monkeypox. They are also highly rated in 2 other conditions, according to our data. Their clinical expertise encompasses Monkeypox, Rabies, Smallpox, and Chickenpox.

View All Doctors
What are the latest Monkeypox Clinical Trials?
A Phase I Randomized Double-blind Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Recombinant Monkeypox Protein Vaccine JT118 in Healthy Adults.
A Phase I Randomized Double-blind Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Recombinant Monkeypox Protein Vaccine JT118 in Healthy Adults.
Enrollment Status: Recruiting
Publish Date: June 05, 2026
Intervention Type: Biological
Study Phase: Phase 1

Summary: This study is a randomized, double-blind, placebo-controlled Phase I clinical trial representing the first-in-human (FIH) investigation of the Monkeypox recombinant protein vaccine JT118. The primary objectives are to evaluate the safety, tolerability, and immunogenicity of two doses of JT118 in healthy adults and to conduct preliminary exploration of vaccination regimens. The study will sequentia...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prospective On-site and Questionnaire Study for the FOLLOW-UP of Mpox Cohort at ITM PLUS Evaluation of the Longevity of B- and T-cell Immune Responses in Former Mpox Patients and Vaccine Recipients
Prospective On-site and Questionnaire Study for the FOLLOW-UP of Mpox Cohort at ITM PLUS Evaluation of the Longevity of B- and T-cell Immune Responses in Former Mpox Patients and Vaccine Recipients
Enrollment Status: Recruiting
Publish Date: March 19, 2026

Summary: The goal of this observational study is to describe possible physical and psychological sequelae after an mpox infection and to evaluate the longevity of B- and T-cell immune responses in former mpox patients and vaccine recipients. The main questions it aims to answer are: * Are there any physical or pschological sequelae after mpox infection? * Is the humoral and/or cellular immune response to M...

View All Clinical Trials